These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36775815)

  • 1. DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection.
    Zhai K; Gong Y; Sun L; He L; Xue Z; Yang Y; Fang M; Zhang J
    Helicobacter; 2023 Apr; 28(2):e12955. PubMed ID: 36775815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of immunodominant Helicobacter pylori proteins with reactivity to H. pylori-specific egg-yolk immunoglobulin.
    Shin JH; Nam SW; Kim JT; Yoon JB; Bang WG; Roe IH
    J Med Microbiol; 2003 Mar; 52(Pt 3):217-222. PubMed ID: 12621086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of anti-Helicobacter pylori urease-specific immunoglobulin in egg yolk using an antigenic epitope of H. pylori urease.
    Shin JH; Roe IH; Kim HG
    J Med Microbiol; 2004 Jan; 53(Pt 1):31-34. PubMed ID: 14663102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection.
    Shin JH; Yang M; Nam SW; Kim JT; Myung NH; Bang WG; Roe IH
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):1061-6. PubMed ID: 12204960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of anti-Helicobacter pylori urease immunoglobulin Y from egg yolk of immunized hens and Lactobacillus johnsonii No.1088 to inhibit the growth of Helicobacter pylori in vitro and in vivo.
    Aiba Y; Umeda K; Rahman S; Nguyen SV; Komatsu Y
    Vaccine; 2019 May; 37(23):3106-3112. PubMed ID: 31031029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of specific anti-Helicobacter pylori yolk antibodies and their antibacterial effects.
    Wang B; Yang J; Cao S; Wang H; Pan X; Zhu J; Zhou Y; Gao L; Li W; Li M
    Int J Clin Exp Pathol; 2014; 7(10):6430-7. PubMed ID: 25400721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effect of anti-VacA egg yolk immunoglobulin (IgY) on Helicobacter pylori-infected mice.
    Hong KS; Ki MR; Ullah HMA; Lee EJ; Kim YD; Chung MJ; Elfadl AK; Park JK; Jeong KS
    Vaccine; 2018 Jan; 36(3):371-380. PubMed ID: 29223485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of multivalent egg yolk IgY antibodies against Helicobacter pylori].
    Sun L; Zhang Z; Zeng B; Chen Y; Li H; Zhou H; Zhang Z; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jun; 34(6):555-560. PubMed ID: 30236210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and property of two specific anti-Helicobacter pylori immunoglobulins in egg yolk].
    Yang T; Yang J; Wang B; Pan X; Li J; Zhu J; Zhou Y; Li M; Cao S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):251-4. PubMed ID: 25652869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection.
    Suzuki H; Nomura S; Masaoka T; Goshima H; Kamata N; Kodama Y; Ishii H; Kitajima M; Nomoto K; Hibi T
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():185-92. PubMed ID: 15298626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary multivalent anti-Helicobacter pylori immunoglobulin Y significantly increase the H. pylori eradication and improve the clinical symptoms in patients.
    Guo R; Wu S; Guan L; Xie Y; Yang X; Li Z; Zhang Z
    Helicobacter; 2021 Oct; 26(5):e12843. PubMed ID: 34382297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effect of functional drinking yogurt containing specific egg yolk immunoglobulin on Helicobacter pylori in humans.
    Horie K; Horie N; Abdou AM; Yang JO; Yun SS; Chun HN; Park CK; Kim M; Hatta H
    J Dairy Sci; 2004 Dec; 87(12):4073-9. PubMed ID: 15545368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of cross-strain inhibitory effects of IgY polyclonal antibody against H. pylori.
    Solhi R; Alebouyeh M; Khafri A; Rezaeifard M; Aminian M
    Microb Pathog; 2017 Sep; 110():682-687. PubMed ID: 28351713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils.
    Nomura S; Suzuki H; Masaoka T; Kurabayashi K; Ishii H; Kitajima M; Nomoto K; Hibi T
    Helicobacter; 2005 Feb; 10(1):43-52. PubMed ID: 15691314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of passive immunization with IgY antibodies to a 58-kDa H. pylori antigen on severe gastritis in BALB/c mouse model.
    Attallah AM; Abbas AT; Ismail H; Abdel-Raouf M; El-Dosoky I
    J Immunoassay Immunochem; 2009; 30(4):359-77. PubMed ID: 19739011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Therapeutic Effects of Egg Yolk Antibody (IgY) in
    Zhang L; Xiao Y; Ji L; Lin M; Zou Y; Zhao J; Zhao S
    J Agric Food Chem; 2021 Nov; 69(46):13691-13699. PubMed ID: 34783242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of rHP-NAP IgY against Helicobacter pylori attachment to AGS cell line.
    Borhani K; Mohabati Mobarez A; Khabiri AR; Behmanesh M; Khoramabadi N
    Microb Pathog; 2016 Aug; 97():231-5. PubMed ID: 27265677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Helicobacter pylori infection in mice with oral administration of egg yolk-driven anti-UreC immunoglobulin.
    Malekshahi ZV; Gargari SL; Rasooli I; Ebrahimizadeh W
    Microb Pathog; 2011 Nov; 51(5):366-72. PubMed ID: 21803146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of specific IgY Helicobacter pylori recombinant OipA protein and assessment of its inhibitory effects towards attachment of H. pylori to AGS cell line.
    Borhani K; Mobarez AM; Khabiri AR; Behmanesh M; Khoramabadi N
    Clin Exp Vaccine Res; 2015 Jul; 4(2):177-83. PubMed ID: 26273576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal immunization with immunodominant epitope peptides derived from HpaA conjugated with CpG adjuvant protected mice against Helicobacter pylori infection.
    Yang WC; Sun HW; Sun HQ; Yuan HM; Li B; Li HB; Hu J; Yang Y; Zou QM; Guo H; Wu C; Chen L
    Vaccine; 2018 Oct; 36(42):6301-6306. PubMed ID: 30217524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.